Abarca executives see plenty of potential for new technologies but note the need to strike the right balance between tech and human intervention.

The post How AI and Machine Learning Can Transform Pharmacy Benefits Management appeared first on MedCity News.

A similar bill appeared last year but did not progress. Given the potential costs of reimbursing prescription digital therapeutics, Congress could be skeptical. Still, with growing attention on mental health, advocates are optimistic.

The post Advocates of Digital Therapies Hope Bill Can Ease Reimbursement appeared first on MedCity News.

Conducted by researchers at the University of Colorado medical school, the new report is the latest to gauge the extent of a costly problem that federal regulators are working to solve: Information about doctors varies from provider directory to provider directory.

The post Study finds inconsistent data in insurers’ online provider directories appeared first on MedCity News.

Hospitals, clinics, nursing homes and other providers collected billions in government aid during the pandemic. Federal auditors may soon come knocking to ensure the money was spent correctly.

The post Feds expected to scrutinize Covid-era payments to providers appeared first on MedCity News.

Disgruntled investors lodged fewer securities claims against life-science companies last year. But when they did sue, investors raised familiar issues, often tied to bad news around clinical research and regulatory approvals, according to a law firm report

The post Report: Class-action Securities Lawsuits Decline but Risks Remain for Life-sciences Companies appeared first on MedCity News.

High prices have drawn other critics, as well, including President Joe Biden. He renewed his call for a broad price cap during his annual State of the Union address. Pharma companies insist they have been part of the solution.

The post California lawsuit targets insulin costs as Biden also takes aim in SOTU appeared first on MedCity News.

The innovation platform promises to match entrepreneurs with the resources they need to advance treatments for stroke care but also to help the device maker process all the new ideas it sees.

The post Medtronic serves up platform for stroke-care startups appeared first on MedCity News.

The industry faces challenges from inflation to labor shortages, according to an annual report from EY. However, there are grounds for optimism and areas to focus on, such as patching up supply chains.

The post Report: Sales, financing slow down for medtech firms appeared first on MedCity News.

President of Humana’s primary care, Reneé Buckingham, addresses the needs of many seniors facing multiple diagnoses and barriers to high-quality care.

The post Humana finds formula for senior-focused care appeared first on MedCity News.

Based in San Francisco, Allermi aims to create a national market for a customizable approach to allergy relief pioneered by a California doctor.

The post Online allergy startup raises $1.25M in pre-seed round appeared first on MedCity News.

Alira Health hopes its purchase of RedCrow will help it stand out from the crowd of consulting firms that help life sciences companies bring drugs to market.

The post Why a consulting firm focused life sciences bought a healthcare crowdsourcing platform appeared first on MedCity News.

Moximed snagged $40 million as it works to secure approval for its device, an implantable shock absorber for the knee designed to put off the need for full joint replacement. CEO Anton Clifford touts that the MISHA Knee System is the first of its kind.

The post New funding fuels device-maker’s pursuit of FDA approval appeared first on MedCity News.

Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there’s a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.

The post Digital transformation: Reimagining clinical trial management appeared first on MedCity News.

The post UK startup hopes FDA nod speeds up adoption of VR therapy appeared first on MedCity News.

Rising deal premiums and shrinking profit margins are threatening the sustainability of the traditional approach to mergers and acqusitions, according to a report by Accenture. The firm expects growth-minded companies will turn to other pathways.

The post As M&A costs rise, new Accenture report offers alternative strategies appeared first on MedCity News.

The company is making its online staffing platform available to people seeking jobs as physical therapists, surgical techs and other allied health professions.

The post Nomad Health raises $105M to support push into new staffing markets appeared first on MedCity News.

A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.

The post MedShift CEO shares vision for growth appeared first on MedCity News.

The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.

The post Project seeks to chart regulatory paths for digital products appeared first on MedCity News.

The peer-reviewed research is among the first to examine the effectiveness of the new crop of digital mental health startups. It looked at people enrolled through their companies in a mental health platform developed by Spring Health.

The post Study shows tech-based program improves workers’ mental health, productivity appeared first on MedCity News.

During first three months of 2022, biopharma tech companies raised less money and made fewer deals than they did in the last three months of 2021. A volatile stock market is exacerbating the trend.

The post Report: Deals continue downward slide for biopharma tech appeared first on MedCity News.

Armed with fresh capital, Nava Benefits hopes to take advantage of what it believes will be a disruption in the way smaller businesses approach health and wellness benefits, including the many digital tools now on the market.

The post Investors funnel $40M into high-tech benefits brokerage appeared first on MedCity News.

Pharma companies often take the blame for high prescription costs. But a new, industry-sponsored survey shifts attention to insurance industry practices.

The post Drug-industry survey blames insurer practices for barriers to care appeared first on MedCity News.

UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases.

The post Novel drug-discovery approach lands big backers appeared first on MedCity News.

The tests could prove useful in screening patients that coud benefit from therapies being tested for Alzheimer’s. But uptake will depend, in part, on reimbursement, according to doctors surveyed by Quest.

The post New Quest Alzheimer’s blood test can help clinical trial sponsors identify patients easily appeared first on MedCity News.

San Francisco-based Frame Fertility has developed a platform geared toward helping people get a headstart on issues that could impact their ability to have children instead of waiting until problems crop up.

The post Startup focused on fertility planning raises $2.8M in seed funding appeared first on MedCity News.

Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.

The post Report: In big shift, medtech executives grow fonder of U.S. regulatory process appeared first on MedCity News.

The partners aim to make decentralized clinical trials more efficient and less expensive through greater use of AI and machine learning.

The post Thread, AWS partner on next-gen tech for clinical trials appeared first on MedCity News.

Brokerage firm Nava Benefits hopes its search engine will become a trusted source of information on thousands of digital health startups aiming to sell their services to employers.

The post New tool aims to ease search for digital health vendors appeared first on MedCity News.

Prenosis is aiming for FDA clearance this year for a diagnostic tool for sepsis, a condition that kills millions of people each year.

The post Diagnostics firm adds investor to bring funding over $20M appeared first on MedCity News.

Lawmakers have acted to strengthen insurance reimbursement for biomarker testing in California, Illinois and Louisiana. Patient advocates and testing companies hope more will act in the coming year.

The post Legislative victories fuel advocates for coverage of biomarker testing appeared first on MedCity News.